Johnson & Johnson (JNJ) Long-Term Investments (2009)
Johnson & Johnson's (JNJ) quarterly Long-Term Investments came in at $19.0 million in Q3 2009, up 5.56% quarter-over-quarter from $18.0 million in Q2 2009.
Powered by 
Analysis
Johnson & Johnson (JNJ) Long-Term Investments (2009) Analysis & Trends
Johnson & Johnson has disclosed Long-Term Investments across 1 years of filings, most recently posting $19.0 million for Q3 2009.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 650.65 Bn | 629.89 Bn | 17.26 Bn | - |
| 2 | AbbVie | 466.34 Bn | 459.82 Bn | 12.70 Bn | 266.00 Mn |
| 3 | Merck | 362.11 Bn | 355.02 Bn | 12.21 Bn | 1.22 Bn |
| 4 | Novartis Ag | 267.81 Bn | 260.52 Bn | 11.24 Bn | 69.00 Mn |
| 5 | Pfizer | 157.31 Bn | 145.91 Bn | 10.94 Bn | 1.56 Bn |
| 6 | Bristol Myers Squibb | 128.75 Bn | 117.69 Bn | 9.25 Bn | 397.00 Mn |
| 7 | Sanofi | 51.80 Bn | 44.84 Bn | 10.79 Bn | 3.73 Bn |
| 8 | Revolution Medicines | 40.91 Bn | 40.91 Bn | - | - |
| 9 | BeOne Medicines | 39.65 Bn | 34.55 Bn | 1.53 Bn | - |
| 10 | Incyte | 25.18 Bn | 20.65 Bn | 1.57 Bn | 345.03 Mn |